Cargando…

Inhibitory Effect of Biotransformed-Fucoidan on the Differentiation of Osteoclasts Induced by Receptor for Activation of Nuclear Factor-κB Ligand

Bone homeostasis is regulated by constant remodeling through osteogenesis by osteoblasts and osteolysis by osteoclasts and osteoporosis can be provoked when this balance is broken. Present pharmaceutical treatments for osteoporosis have harmful side effects and thus, our goal was to develop therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Bobae, Yu, Sun Nyoung, Kim, Sang-Hun, Lee, Junwon, Choi, Sung Jong, Chang, Jeong Hyun, Yang, Eun Ju, Kim, Kwang-Youn, Ahn, Soon-Cheol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Microbiology and Biotechnology 2022
Materias:	Research article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628933/ https://www.ncbi.nlm.nih.gov/pubmed/35879294 http://dx.doi.org/10.4014/jmb.2203.03001

Ejemplares similares

Nicotinamide phosphoribosyltransferase inhibits receptor activator of nuclear factor-κB ligand-induced osteoclast differentiation in vitro
por: Baek, Jong Min, et al.
Publicado: (2017)

Extracts of Flavoparmelia sp. Inhibit Receptor Activator of Nuclear Factor-κB Ligand-Mediated Osteoclast Differentiation
por: Kim, Kwang-Jin, et al.
Publicado: (2019)

Inhibitory Effects of Laminaria japonica Fucoidans Against Noroviruses
por: Kim, Hyojin, et al.
Publicado: (2020)

Fucoidan, a Sulfated Polysaccharide, Inhibits Osteoclast Differentiation and Function by Modulating RANKL Signaling
por: Kim, Young Woo, et al.
Publicado: (2014)

Involvement of Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-induced Incomplete Cytokinesis in the Polyploidization of Osteoclasts
por: Takegahara, Noriko, et al.
Publicado: (2016)

Placotylene A, an Inhibitor of the Receptor Activator of Nuclear Factor-κB Ligand-Induced Osteoclast Differentiation, from a Korean Sponge Placospongia sp.
por: Kim, Hiyoung, et al.
Publicado: (2014)

Dendrobium moniliforme Exerts Inhibitory Effects on Both Receptor Activator of Nuclear Factor Kappa-B Ligand-Mediated Osteoclast Differentiation in Vitro and Lipopolysaccharide-Induced Bone Erosion in Vivo
por: Baek, Jong Min, et al.
Publicado: (2016)

Anti-Müllerian Hormone Negatively Regulates Osteoclast Differentiation by Suppressing the Receptor Activator of Nuclear Factor-κB Ligand Pathway
por: Kim, Jung Ha, et al.
Publicado: (2021)

Fexaramine Inhibits Receptor Activator of Nuclear Factor-κB Ligand-induced Osteoclast Formation via Nuclear Factor of Activated T Cells Signaling Pathways
por: Zheng, Ting, et al.
Publicado: (2017)

Silibinin induces mitochondrial NOX4-mediated endoplasmic reticulum stress response and its subsequent apoptosis
por: Kim, Sang-Hun, et al.
Publicado: (2016)

Humanin suppresses receptor activator of nuclear factor-κB ligand-induced osteoclast differentiation via AMP-activated protein kinase activation
por: Kang, Namju, et al.
Publicado: (2019)

Enzyme-Aided Extraction of Fucoidan by AMG Augments the Functionality of EPCs through Regulation of the AKT/Rheb Signaling Pathway
por: Rethineswaran, Vinoth Kumar, et al.
Publicado: (2019)

Inhibitory Effects of Gold and Silver Nanoparticles on the Differentiation into Osteoclasts In Vitro
por: Lee, Daye, et al.
Publicado: (2021)

Adrenomedullin inhibits osteoclast differentiation through the suppression of receptor activator of nuclear factor-κB ligand-induced nuclear factor-κB activation in glucocorticoid-induced osteoporosis
por: Liu, Yuanxin, et al.
Publicado: (2017)

Inhibition of Autophagy Promotes Salinomycin-Induced Apoptosis via Reactive Oxygen Species-Mediated PI3K/AKT/mTOR and ERK/p38 MAPK-Dependent Signaling in Human Prostate Cancer Cells
por: Kim, Kwang-Youn, et al.
Publicado: (2017)

Mitochondrial ROS activates ERK/autophagy pathway as a protected mechanism against deoxypodophyllotoxin-induced apoptosis
por: Kim, Sang-Hun, et al.
Publicado: (2017)

Interleukin-1 induces receptor activator of nuclear factor-κB ligand-independent osteoclast differentiation in RAW264.7 cells
por: Liao, Rongdong, et al.
Publicado: (2021)

Effect of Cornus Officinalis on Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL)-induced Osteoclast Differentiation
por: Kim, Jung Young, et al.
Publicado: (2012)

α-Tocopheryl Succinate Inhibits Osteoclast Formation by Suppressing Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL) Expression and Bone Resorption
por: Kim, Ha-Neui, et al.
Publicado: (2012)

Artemisia annua extract prevents ovariectomy-induced bone loss by blocking receptor activator of nuclear factor kappa-B ligand-induced differentiation of osteoclasts
por: Lee, Sun Kyoung, et al.
Publicado: (2017)

Salinomycin enhances doxorubicin-induced cytotoxicity in multidrug resistant MCF-7/MDR human breast cancer cells via decreased efflux of doxorubicin
por: KIM, KWANG-YOUN, et al.
Publicado: (2015)

Paeoniflorin Inhibits Receptor Activator for Nuclear Factor κB (RANK) Ligand-Induced Osteoclast Differentiation In Vitro and Particle-Induced Osteolysis In Vivo
por: Li, Zhuokai, et al.
Publicado: (2018)

Effects of urolithin A on osteoclast differentiation induced by receptor activator of nuclear factor-κB ligand via bone morphogenic protein 2
por: Wang, Zhe, et al.
Publicado: (2022)

The Inhibitory Effects of Forsythia Koreana Extracts on the Metastatic Ability of Breast Cancer Cells and Bone Resorption by Osteoclasts
por: Kim, Yu Li, et al.
Publicado: (2016)

Fucoidan Promotes the Reconstruction of Skin Equivalents
por: Song, Yu Seok, et al.
Publicado: (2014)

Bone destruction by receptor activator of nuclear factor κB ligand-expressing T cells in chronic gouty arthritis
por: Lee, Sung-Ji, et al.
Publicado: (2011)

Amorphigenin inhibits Osteoclast differentiation by suppressing c-Fos and nuclear factor of activated T cells
por: Kim, Bong Gyu, et al.
Publicado: (2010)

Selaginella tamariscina water extract inhibits receptor activator for the nuclear factor-κB ligand-induced osteoclast differentiation by blocking mitogen-activated protein kinase and NF-κB signaling
por: Shim, Ki-Shuk, et al.
Publicado: (2012)

Inhibitory effect of ribbon-type NF-κB decoy oligodeoxynucleotides on osteoclast induction and activity in vitro and in vivo
por: Kunugiza, Yasuo, et al.
Publicado: (2006)

LIM Homeobox Transcription Factor 1-β Expression is Upregulated in Patients with Osteolysis after Total Ankle Arthroplasty and Inhibits Receptor Activator of Nuclear Factor-κB Ligand-Induced Osteoclast Differentiation in Vitro
por: Kim, Kabsun, et al.
Publicado: (2022)

Actin-binding LIM protein 1 regulates receptor activator of NF-κB ligand-mediated osteoclast differentiation and motility
por: Jin, Su Hyun, et al.
Publicado: (2018)

Inhibitory Effect of Probenecid on Osteoclast Formation via JNK, ROS and COX-2
por: Cheng, Mi Hyun, et al.
Publicado: (2020)

Biotransformed Metabolites of the Hop Prenylflavanone Isoxanthohumol
por: Kim, Hyun Jung, et al.
Publicado: (2019)

Fucoidans in Nanomedicine
por: Chollet, Lucas, et al.
Publicado: (2016)

Are Helicobacter pylori Infection and Fucoidan Consumption Associated with Fucoidan Absorption?
por: Tomori, Makoto, et al.
Publicado: (2020)

Osteoprotegerin Induces Apoptosis of Osteoclasts and Osteoclast Precursor Cells via the Fas/Fas Ligand Pathway
por: Liu, Wei, et al.
Publicado: (2015)

Biotransformation of dihydrocapsaicin by human intestinal fungi and the inhibitory effects of metabolites against LSD1
por: He, Xin, et al.
Publicado: (2022)

Tartrate-resistant acid phosphatase 5b is a marker of osteoclast number and volume in RAW 264.7 cells treated with receptor-activated nuclear κB ligand
por: LV, YUANDONG, et al.
Publicado: (2015)

The Anticancer Effect of Fucoidan in PC-3 Prostate Cancer Cells
por: Boo, Hye-Jin, et al.
Publicado: (2013)

Increased osteoclastic activity in acute Charcot’s osteoarthopathy: the role of receptor activator of nuclear factor-kappaB ligand
por: Mabilleau, G., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_89v4l9fh9j984mmlglu35gdsrs